An assessment of Movement Disorder Society Task Force diagnostic criteria for mild cognitive impairment in Parkinson's disease
EUROPEAN JOURNAL OF NEUROLOGY, cilt.25, sa.1, ss.148-153, 2018 (SCI-Expanded, Scopus)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 25 Sayı: 1
- Basım Tarihi: 2018
- Doi Numarası: 10.1111/ene.13467
- Dergi Adı: EUROPEAN JOURNAL OF NEUROLOGY
- Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
- Sayfa Sayıları: ss.148-153
- Anahtar Kelimeler: mild cognitive impairment, Parkinson's disease, DEMENTIA, VALIDITY, MOCA, MCI
- İstanbul Üniversitesi Adresli: Evet
Özet
Background and purposeCognitive impairment is one of the most disabling non-motor symptoms of Parkinson's disease. Mild cognitive impairment constitutes a major risk for the development of Parkinson's disease dementia in the course of the disease. A Movement Disorder Society Task Force proposed diagnostic criteria for mild cognitive impairment in Parkinson's disease (PD-MCI), comprising two operational levels: Level I and Level II. The objective of our study was to test the accuracy of Level I versus Level II diagnostic criteria.